 The use of 3D printing technology in the pharmaceutical industry has opened up a new chapter in the production of solid medicines. It allows for the modification of dosages by adjusting the volume of tablets according to the desired dose. Research has focused on polymer selection for FDM-based 3D printing of tablets, with particular attention paid to the characteristics of polymers such as polylactic acid, polyvinyl alcohol, polycaprolactone, polyvinyl pyrroladone, polyethylene oxide, ethylene vinyl acetate, ethyl cellulose, hydroxypropyl methyl cellulose, and hydroxypropyl cellulose. These polymers are selected based on their ability to control the drug release profile from the 3D printed tablets. This article was authored by Sylvia Siraini, Yolthina Bimowanti, and Aretha Kearney-Owan.